Literature DB >> 9429150

Frequency of the G6PD nt 1311 C/T polymorphism in English and Iranian populations: relevance to studies of X chromosome inactivation.

Y Mortazavi1, R Chopra, E C Gordon-Smith, T R Rutherford.   

Abstract

X chromosome inactivation is widely studied using DNA sequence polymorphisms and DNA methylation as a surrogate measure of inactivation, but the correlation of methylation with inactivation is not perfect. Thus, it may be better to study sequence polymorphisms expressed in the mRNA. A recent paper reported use of a silent C/T polymorphism at nt 1311 of the G6PD cDNA, and this polymorphism was reported to have a frequency of 40% in all ethnic groups. We have screened 218 English and 50 Iranian subjects by PCR and restriction digestion; 53/218 (24%) British and 22/50 (44%) Iranian subjects were heterozygous. Thus, X inactivation studies using this polymorphism may be useful in some populations, including Iran, but much less so in the UK.

Entities:  

Mesh:

Year:  1997        PMID: 9429150      PMCID: PMC1051159          DOI: 10.1136/jmg.34.12.1028

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  5 in total

1.  Studying X inactivation.

Authors:  J T Curnutte; P J Hopkins; W Kuhl; E Beutler
Journal:  Lancet       Date:  1992-03-21       Impact factor: 79.321

2.  The NT 1311 polymorphism of G6PD: G6PD Mediterranean mutation may have originated independently in Europe and Asia.

Authors:  E Beutler; W Kuhl
Journal:  Am J Hum Genet       Date:  1990-12       Impact factor: 11.025

Review 3.  The genetics of glucose-6-phosphate dehydrogenase deficiency.

Authors:  E Beutler
Journal:  Semin Hematol       Date:  1990-04       Impact factor: 3.851

4.  Transcriptional analysis of the active X-chromosome in normal and clonal hematopoiesis.

Authors:  J T Prchal; Y L Guan; J F Prchal; F Barany
Journal:  Blood       Date:  1993-01-01       Impact factor: 22.113

5.  Origin and spread of the glucose-6-phosphate dehydrogenase variant (G6PD-Mediterranean) in the Middle East.

Authors:  B Kurdi-Haidar; P J Mason; A Berrebi; G Ankra-Badu; A al-Ali; A Oppenheim; L Luzzatto
Journal:  Am J Hum Genet       Date:  1990-12       Impact factor: 11.025

  5 in total
  6 in total

1.  The glucose-6-phosphate dehydrogenase Mahidol variant protects against uncomplicated Plasmodium vivax infection and reduces disease severity in a Kachin population from northeast Myanmar.

Authors:  Haoan Yi; Hong Li; Luxin Liang; Yanrui Wu; Lu Zhang; Wanfang Qiu; Weiyang Jiang; Fang Yang; Qing Li; Zhaoqing Yang; Chengqi Wang; Liwang Cui; Yongshu He
Journal:  Infect Genet Evol       Date:  2019-07-24       Impact factor: 3.342

2.  The prevalence of factor V Leiden, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T among G6PD deficient individuals from Western Iran.

Authors:  Hadi Mozafari; Zohreh Rahimi; Azadeh Heidarpour; Mahsa Fallahi; Adraiana Muniz
Journal:  Mol Biol Rep       Date:  2009-02-15       Impact factor: 2.316

3.  Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in Jeddah, Kingdom of Saudi Arabia.

Authors:  Soad K Al-Jaouni; Jummanah Jarullah; Essam Azhar; Kamran Moradkhani
Journal:  BMC Res Notes       Date:  2011-10-24

4.  Detection of 1311 polymorphism in the glucose-6-phosphate dehydrogenase gene by microarray technique.

Authors:  Sule Menziletoglu Yildiz; Sedefgul Yuzbasioglu Ariyurek; Murat Tahiroglu; Kiymet Aksoy
Journal:  Arch Med Sci       Date:  2011-09-02       Impact factor: 3.318

5.  Population study of 1311 C/T polymorphism of Glucose 6 Phosphate Dehydrogenase gene in Pakistan - an analysis of 715 X-chromosomes.

Authors:  Bushra Moiz; Amna Nasir; Tariq Moatter; Zulfiqar Ali Naqvi; Mohammad Khurshid
Journal:  BMC Genet       Date:  2009-07-30       Impact factor: 2.797

6.  Evaluation of X-Chromosome Inactivation Patterns in Patients with Acute Myeloid Leukemia during Remission.

Authors:  Yousef Mortazavi; Saeid Kaviani; Fatemeh Mirzamohammadi; Kamran Alimoghaddam; Ali Akbar Pourfathollah; Oveis Salehi
Journal:  ISRN Hematol       Date:  2012-10-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.